Introduction
Chronic idiopathic thrombocytopenic purpura (chronic ITP) is an autoimmune disorder characterized by destruction of autoantibody-bound platelets by the reticuloendothelial system.1 ' used without any promising result. Three daily doses of vinblastine-loaded platelets were tried. High fever, diarrhoea, and abdominal distension developed at the same time when marked leukopenia (1.3 x 109/l) occurred, 2 days after the last dose of vinblastine-loaded platelets. A panophthalmitis rapidly followed which proved to be due to Ps. aeruginosa septicaemia. She subsequently recovered from the serious episode but with permanent loss of vision in her left eye. A summary of clinical data is shown in Table I . All patients received corticosteroids as an initial treatment and were either steroid-nonresponsive or steroid-dependent. Cushing's effect developed in 5 patients, and was severe in two. Serious complications occurred as a consequence of splenectomy in 5 patients (Cases 1-5). One patient (Case 6) had pseudomonas septicaemia following vinblastineinduced leukopenia. Three who had splenectomyrelated complications died, one from massive intra-abdominal bleeding, two from uncontrollable infection. Thrombocytopenic episodes usually occurred during serious complications.
Discussion
Corticosteroids are accepted as conventional treatment of ITP.7 However, long-term corticosteroid administration can lead to many undesirable effects. Among them are hypertension, hyperglycaemia, Cushing's appearance, myopathy and increased susceptibility to infection.8 These side effects, especially the last one, may have some considerable influence on the outcome of splenectomy. Our first case demonstrated an effect of long-term corticosteroid administration on tissue healing. Rupture of a ligated vessel was a possible cause of the fatal intra-abdominal bleeding. Corticosteroids might have delayed clearance of bacterial infections in Cases 2-4.
Splenectomy has been accepted as an effective treatment of ITP after failure of corticosteroids. Serious complication following splenectomy is uncommon.9 Block et al.10 reported three postoperative deaths (4.4%) among 67 ITP patients undergoing splenectomy. In their series two patients died within 10 days after operation from the effects of haemorrhage. It is possible that corticosteroids might have retarded clearance of microorganisms leading to uncontrollable infections. Corticosteroids may also hamper inflammatory reaction and delay early recognition of infectious process, as occurred in patients 2 and 3.
One patient had ischaemic gangrene of the jejunum 3 weeks after splenectomy. This complication was not the result of rebound thrombocytosis since the platelet count was low at that time. Although detection of lupus circulating anticoagulant'1 was not done, the negative immune profiles and the occurrence of such complications at short duration after splenectomy made lupus circulating anticoagulant an unlikely cause of intestinal ischaemia. The relationship between splenectomy and intestinal gangrene is unknown although one can speculate about disturbance of the mesenteric circulation during the operation.
A variety of non-steroidal immunosuppressive agents have been used in the treatment of ITP refractory to splenectomy and use of corticosteroids. In order to reduce both short and longterm hazards from such agents, a variety of therapeutic options including dosage modification have been tried. Vinblastine-loaded platelets were claimed to be effective in refractory ITP.12 Unless removal of free drug is inadequate, serious side effects including neutropenia are unusual. Our patient 6 was an exceptional case, having severe granulocytopenia following vinblastine-loaded platelets. Permanent loss of vision in her left eye was a serious consequence of complicating pseudomonas septicaemia and panophthalmitis.
Clinicians need to be aware that serious complications may occur in ITP patients during treatment. Early recognition of such complications is the only way to save the patients. Among predisposing factors are combination therapy especially with corticosteroids and splenectomy. Elective splenectomy should be avoided in any patients with Cushing's effect. Recurrent thrombocytopenia was a constant finding and may be used, combined with other manifestations, as a warning sign of serious consequences.
